Form D · Biotechnology

PROTEOGENIX INC

Costa Mesa, CA · CIK 0001179366

Offering snapshot reported Apr 14, 2010 · SEC filing

Reported sold
$4M
Offering amount: $4.4M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 5, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 14, 2010Initial$4,000,000No comparison5SEC filing
Aug 13, 2009Initial$4,002,500No comparison5SEC filing
Mar 2, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-140582

Source: Form D, filed Apr 14, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mike Allen Executive
Steven G. Burrill Director
G. Steven Burrill Director
Fred Cohen Director
Richard Creager Director
Robert M. Di Tullio Executive
Michael G. Gravett Executive
Thomas H. Grove Executive
Durlin E. Hickok Executive
Vijay Lathi Director
David Levison Director
Donald Mooney Director, Executive
Srinivasa Nagalla Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3545 Howard Way
Costa Mesa, CA, 92626